University of Nottingham
  

Bacteria-resistant coatings to reduce infection

Camstent catheter on surgical gloves

We have developed a patented class of materials which are resistant to bacterial attachment. Used as a medical device coating, the materials resist bacterial attachment, rather than killing the bacteria. This has the advantage that that biofilm colonisation is prevented, potentially preventing infection in patients, and that the coating should therefore not contribute to bacterial resistance.

Camstent urinary catheters

This technology, developed by Professor Morgan Alexander, Professor Derek Irvine and Professor Paul Williams, has been commercialised for urinary catheters in collaboration with Camstent.  Urinary catheters represent one of the highest causes of hospital acquired infections, costing billions of pounds each year worldwide, and which can be extremely dangerous for patients. 

This technology, developed by Professor Morgan AlexanderProfessor Derek Irvine and Professor Paul Williams, has been commercialised for urinary catheters in collaboration with Camstent.  Urinary catheters represent one of the highest causes of hospital acquired infections, costing billions of pounds each year worldwide, and which can be extremely dangerous for patients. 

Technology updates

Key papers

 

Other applications

We are now developing new polymers:

  • With pro and anti inflammatory immune response
  • To reduce infection rates for endotracheal tubes
  • To reduce infection rates in external fixtures
  • To reduce infection rates with venous catheters

 Find out more about the EPSRC Biomaterials Discovery Programme

Lead experts

Recognition

Camstent's collaboration with the University of Nottingham was shortlisted for the Times Higher Education (THE) awards 2018 in the category "Most Innovative Contribution to Business-University Collaboration"

The technology was selected to feature in the Royal Society Summer Exhibition 2019

Summer Exhibition Camstent
 

 

To license this technology

Licence and commercial collaboration or investment opportunities are available for this technology. Contact tto@nottingham.ac.uk

 

This work has been funded by Wellcome Trust and EPSRC